Product Information
CLONAZEPAM 2 MG ODT is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.8510 per EA under NDC 00093929467. Its NADAC has been published 213 times since Jun 1, 2022.
Strength
2 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093929467
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CLONAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA077194On Market Since
3/2/2022
Pharmacological Classes
Price Statistics
The NADAC for CLONAZEPAM 2 MG ODT has been published 213 times since Jun 1, 2022, and over the history we have for it it has declined 15.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8510 per EA |
|---|---|
| All-time high | $1.2990 (Feb 15, 2023) |
| All-time low | $0.6478 (Jan 17, 2024) |
| 52-week high | $1.0328 |
| 52-week low | $0.8241 |
| Median price | $0.9885 |
| Average price | $0.9923 |
| Largest weekly change | +63.3% (Mar 20, 2024) |
| Weeks tracked | 213 |
| Tracking since | Jun 1, 2022 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 96% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CLONAZEPAM 2 MG ODT?
The current National Average Drug Acquisition Cost (NADAC) for CLONAZEPAM 2 MG ODT, manufactured by Teva Pharmaceuticals USA Inc., is $0.8510 per EA (NDC 00093929467), effective Jun 24, 2026.
How has the price of CLONAZEPAM 2 MG ODT changed over time?
Over the history we have for it, the NADAC for CLONAZEPAM 2 MG ODT has declined 15.1%. It has been tracked across 213 weekly CMS publications since Jun 1, 2022.
What are the highest and lowest recorded NADAC prices for CLONAZEPAM 2 MG ODT?
Since Jun 1, 2022, the NADAC for CLONAZEPAM 2 MG ODT has ranged from a low of $0.6478 (Jan 17, 2024) to a high of $1.2990 (Feb 15, 2023), with a median of $0.9885 per EA.
Are there cheaper alternatives to CLONAZEPAM 2 MG ODT?
Yes. 6 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, CLONAZEPAM 2 MG TABLET, is $0.0378 per EA — about 96% below CLONAZEPAM 2 MG ODT.
Who manufactures CLONAZEPAM 2 MG ODT?
CLONAZEPAM 2 MG ODT (NDC 00093929467) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification